Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human ??2m: An animal model of HLA-B27-associated human disorders, Cell, vol.63, issue.5, pp.1099-1112, 1990. ,
DOI : 10.1016/0092-8674(90)90512-D
Innate immunity in host-microbial interactions: Beyond B27 in the spondyloarthropathies, Current Opinion in Rheumatology, vol.14, issue.4, pp.373-382, 2002. ,
DOI : 10.1097/00002281-200207000-00007
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity, Annals of the Rheumatic Diseases, vol.59, issue.12, pp.945-953, 2000. ,
DOI : 10.1136/ard.59.12.945
Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis, Annals of the Rheumatic Diseases, vol.60, issue.4, pp.316-321, 2001. ,
DOI : 10.1136/ard.60.4.316
Immunog??n??tique de??la??spondylarthrite ankylosante, La Revue de M??decine Interne, vol.27, issue.10, pp.762-771, 2006. ,
DOI : 10.1016/j.revmed.2006.05.005
CD28/B7 SYSTEM OF T CELL COSTIMULATION, Annual Review of Immunology, vol.14, issue.1, pp.233-258, 1996. ,
DOI : 10.1146/annurev.immunol.14.1.233
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION, Annual Review of Immunology, vol.24, issue.1, pp.65-97, 2006. ,
DOI : 10.1146/annurev.immunol.24.021605.090535
CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression, The Journal of Immunology, vol.165, issue.3, pp.1352-1356, 2000. ,
DOI : 10.4049/jimmunol.165.3.1352
CTLA-4 Control over Foxp3+ Regulatory T Cell Function, Science, vol.322, issue.5899, pp.271-275, 2008. ,
DOI : 10.1126/science.1160062
A Native Soluble Form of CTLA-4, Cellular Immunology, vol.201, issue.2, pp.144-153, 2000. ,
DOI : 10.1006/cimm.2000.1649
The soluble CTLA-4 receptor: a new marker in autoimmunes diseases, Arch Immunol Ther Exp, vol.53, pp.336-341, 2005. ,
Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease, The Journal of Immunology, vol.164, issue.10, pp.5015-5018, 2000. ,
DOI : 10.4049/jimmunol.164.10.5015
Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence, Journal of Neuroimmunology, vol.130, issue.1-2, pp.224-232, 2002. ,
DOI : 10.1016/S0165-5728(02)00228-X
Increased Expression of Soluble Cytotoxic T-Lymphocyte-Associated Antigen-4 Molecule in Patients with Systemic Lupus Erythematosus, Scandinavian Journal of Immunology, vol.164, issue.6, pp.568-572, 2003. ,
DOI : 10.1006/bbrc.1996.1256
Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus, Rheumatology, vol.44, issue.8, pp.989-994, 2005. ,
DOI : 10.1093/rheumatology/keh663
Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis, Rheumatology, vol.43, issue.10, pp.1261-1266, 2004. ,
DOI : 10.1093/rheumatology/keh303
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease, Nature, vol.423, issue.6939, pp.506-511, 2003. ,
DOI : 10.1038/nature01621
The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy, Arthritis & Rheumatism, vol.57, issue.10, pp.1218-1227, 1991. ,
DOI : 10.1002/art.1780341003
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index, J Rheumatol, vol.21, pp.2286-2291, 1994. ,
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index (BASFI), J Rheumatol, vol.21, pp.2281-2285, 1994. ,
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-324, 1988. ,
DOI : 10.1002/art.1780310302
The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthritis & Rheumatism, vol.31, issue.11, pp.1271-1277, 1982. ,
DOI : 10.1002/art.1780251101
Multisite comparison of CD4 and CD8 Tlymphocyte counting by single-versus multiple-platform methodologies: evaluation of Beckman Coulter flow-count fluorospheres and the tetraONE system. The NIAID DAIDS New Technologies Evaluation Group, Clin Diagn Lab Immunol, vol.7, pp.344-351, 2000. ,
Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-?? dependent but does not confer a regulatory phenotype, Blood, vol.110, issue.8, pp.2983-2990, 2007. ,
DOI : 10.1182/blood-2007-06-094656
A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Research, vol.29, issue.9, p.45, 2001. ,
DOI : 10.1093/nar/29.9.e45
Role of CD28/B7 Costimulation in the Dexamethasone-Induced Suppression of IFN-??, Journal of Interferon & Cytokine Research, vol.20, issue.11, pp.927-934, 2000. ,
DOI : 10.1089/10799900050198363
Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics, Allergy, vol.133, issue.6, pp.774-779, 2005. ,
DOI : 10.1016/j.jaci.2004.03.050
Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy, Arthritis & Rheumatism, vol.30, issue.5, pp.1624-1635, 2004. ,
DOI : 10.1002/art.20211
CD25 bright CD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease, Arthritis Research & Therapy, vol.6, issue.4, pp.335-346, 2004. ,
DOI : 10.1186/ar1192
Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells, European Journal of Immunology, vol.32, issue.10, pp.2888-2896, 2002. ,
DOI : 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F
The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium, Arthritis & Rheumatism, vol.91, issue.1, pp.110-114, 1996. ,
DOI : 10.1002/art.1780390115
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF?? Therapy, The Journal of Experimental Medicine, vol.155, issue.3, pp.277-285, 2004. ,
DOI : 10.1186/ar414
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis, Proceedings of the National Academy of Sciences, vol.105, issue.49, pp.19396-19401, 2008. ,
DOI : 10.1073/pnas.0806855105
Abatacept in spondyloarthritis refractory to tumour necrosis factor ?? inhibition, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.151-152, 2009. ,
DOI : 10.1136/ard.2008.097030